Regeneron Pharmaceuticals
REGN
REGN
901 hedge funds and large institutions have $44.3B invested in Regeneron Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 141 funds opening new positions, 374 increasing their positions, 281 reducing their positions, and 135 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
14% less capital invested
Capital invested by funds: $51.6B → $44.3B (-$7.33B)
18% less funds holding in top 10
Funds holding in top 10: 17 → 14 (-3)
21% less call options, than puts
Call options by funds: $1.02B | Put options by funds: $1.29B
Holders
901
Holding in Top 10
14
Calls
$1.02B
Puts
$1.29B
Top Buyers
| 1 | +$280M | |
| 2 | +$244M | |
| 3 | +$211M | |
| 4 |
Capital World Investors
Los Angeles,
California
|
+$163M |
| 5 |
SGA
Sustainable Growth Advisers
Stamford,
Connecticut
|
+$120M |
Top Sellers
| 1 | -$668M | |
| 2 | -$479M | |
| 3 | -$428M | |
| 4 |
Goldman Sachs
New York
|
-$163M |
| 5 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$161M |